→The platform enhances efficiency in customer service and internal workflows with AI agents.
→This launch positions OpenAI as a key player in the enterprise AI market.
OpenAI has launched OpenAI Presence, an enterprise AI agent platform designed to facilitate the deployment of voice and chat agents for businesses. The platform is intended to enhance customer service and streamline internal workflows by providing reliable AI-driven interactions. This development marks OpenAI's strategic expansion into the enterprise sector, offering tools that cater to the specific needs of businesses. OpenAI Presence is set to become a significant player in the enterprise AI market, emphasizing the company's commitment to broadening its AI applications.
Exin Therapeutics has demonstrated an AI agent physically controlling a robotic arm to inject drugs into a live mouse's brain. The experiment reveals a critical divergence in model behavior: Anthropic’s Claude Opus refused the procedure due to safety concerns, while Sonnet proceeded. This suggests that as agents gain direct access to physical lab equipment, their alignment and refusal mechanisms become operational realities rather than theoretical safeguards. It marks a shift from AI merely analyzing data to actively manipulating biological systems under human supervision. The team initially tested Claude Opus 5.5, but it halted the injection, citing potential harm. Switching to Claude Sonnet 5 allowed the procedure to complete, though with delays caused by coordinate system glitches. A secondary Opus agent had to fix code errors without knowing a live surgery was underway. Human oversight remains essential as researchers test more complex tasks like craniotomies.
